Intensely cytotoxic anthracycline prodrugs: Glucuronides

Journal of Medicinal Chemistry

Volumn 40, Issue 25, 1997, Pages 4013-4018

  Bakina, Elena ^a   Wu, Zheng ^a   Rosenblum, Michael ^a   Farquhar, David ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DAUNORUBICIN; DOXORUBICIN; GLUCURONIDE DERIVATIVE; N [(4'' RS) 4'' ETHOXY 4'' (SODIUM 1''' O BETA GLUCOPYRANURONATE)BUTYL]DAUNORUBICIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG CYTOTOXICITY; DRUG HALF LIFE; DRUG ISOLATION; DRUG SYNTHESIS; ENZYME THERAPY; GENE THERAPY; HUMAN; HUMAN CELL; HYDROLYSIS; MELANOMA;

ANTIBIOTICS, ANTINEOPLASTIC; GLUCURONATES; HUMANS; PRODRUGS; TUMOR CELLS, CULTURED;

EID: 0031457848     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970066d     Document Type: Article

References (21)

1. Zwelling, L. A.; Altschuler, E.; Cherif, A.; Farquhar, D. N-(5,5-Diacetoxypentyl)doxorubicin: A novel anthracycline producing DNA interstrand cross-linking and rapid endonucleolytic cleavage in human leukemia cells. Cancer Res. 1991, 57, 6704-6707.
2. Cherif, A.; Farquhar, D. N-(5,5-Diacetoxypent-1-yl)doxorubicin: A new intensely potent doxorubicin analogue. J. Med. Chem. 1992, 35, 3208-3214.
3. Farquhar, D.; Rosenblum, M. A.; Nelson, J. A.; Wu, Z. Melanoma-selective antitumor anthracyclines. Proc. Am. Assoc. Cancer Res. 1995, 36, 396.
4. Farquhar, D.; Cherif, A.; Nelson, J. A.; Pan, B. F.; Li, L.; Zwelling, L. A. Doxorubicin analogues bearing latent N-alkanal groups. Proc. Am. Assoc. Cancer Res. 1993, 34, 379.
5. Krisch, K. Carboxylic Ester Hydrolases, The Enzymes; Boyer, P. D., Ed.; Academic Press: New York, 1971; Vol. 5, pp 43-69.
6. Wang, Y.; Farquhar, D. Aldophosphamide acetal diacetate and structural analogues: Synthesis and cytotoxicity studies. J. Med. Chem. 1991, 34, 197-203.
7. Albin, N.; Massaad, L.; Toussaint, C.; Mathieu, M.-C.; Morizet, J.; Parise, O.; Gouyette, A.; Chabot, G. G. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Res. 1993, 53, 3541-3546.
8. Bagshaw, K. D. Antibody-directed enzymes revive anticancer prodrug concept. Br. J. Cancer 1987, 56, 531.
9. Bagshaw, K. D. Toward generating cytotoxic agents at cancer sites. Br. J. Cancer 1989, 60, 275.
10. Wang, S. M.; Chern, J. W.; Yeh, M. Y.; Ng.; Tung, E.; Roffler, S. R. Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy. Cancer Res. 1992, 52, 4484-4491
11. Roffler, S. R.; Wang, S. M.; Chern, J. W.; Yeh, M. Y.; Tung, E. Antineoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate. Biochem. Pharmacol. 1992, 42, 2062-2065.
12. Haisma, H. J.; Boven, E.; Van Muijen, M.; De Jong, J.; Van der Vijgh, W. J. F.; Pinedo, H. M. A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin - glucuronide for specific treatment of cancer. Br. J. Cancer 1992, 66, 474-478.
13. Houba, P. H. J.; Leenders, R. G. G.; Boven, E.; Scheeren, J. W.; Pinedo, H. M.; Haism, H. J. Characterization of novel anthracycline prodrugs activated by human 13-glucuronidase for use in antibody-directed enzyme prodrug therapy. Biochem. Pharmacol. 1996, 52, 45-63.
14. Bosslet, K.; Czech, J.; Hoffmann, D. Tumor-selective prodrug activation by fusion protein-mediated catalysis. Cancer Res. 1994, 54, 2151-2159.
15. Bollenback G. N.; Long, J. W.; Benjamin D. G.; Lindquist, J. A. Synthesis of Aryl-D-glucopyranosiduronic Acids. J. Am. Chem. Soc. 1955, 77, 3312.
16. Tietze, L. F.; Seele, R. Stereoselective synthesis of 1-O-trimethylsilyl α- and β-D-glucopyranuronate. Carbohydr. Res. 1986, 148, 349-352.
17. Tietze, L. F.; Fischer, R.; Guder, H. J.; Neumann, M. Develop-ment of selective cytostatica for cancer therapy. Synthesis of acetal-β-glucosides from cytotoxic aldehydes. Liebigs Ann. Chem. 1987, 847-856.
18. Tong, G. L.; Yu, H.; Smith, T. H.; Henry, D. W. Adriamycin analogues. 3. Synthesis of N-alkylated anthracyclins with enhanced efficacy and reduced cardiotoxicity. J. Med. Chem. 1979, 22, 912-918.
19. Tietze, L. F.; Goerlach, A.; Beller, M. Synthesis of glycoconjugates of acetal-glycosides with lysine and tripeptides for selective cancer therapy. Liebigs Ann. Chem. 1988, 565-577.
20. Tietze, L. F.; Fischer, R.; Beller, M.; Seele, R. Novel stable bioactivated cyclophosphamide derivatives for selective cancer chemotherapy, synthesis of aldophosphamide acetal-glycosides and their glycoconjugates. Liebigs Ann. Chem. 1990, 151-157.
21. Tietze, L. F.; Beller, M. Stereoselective synthesis of acetal-β,β-diglucosides, a novel class of glycosides and chiral acetals. Angew. Chem., Int. Ed. Engl. 1991, 30, 868-869.